98 related articles for article (PubMed ID: 4773983)
1. [The Parkinson syndrome].
Presthus J
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2111. PubMed ID: 4773983
[No Abstract] [Full Text] [Related]
2. [Current treatment of the Parkinsonian syndrome].
Voiculescu V
Neurol Psihiatr Neurochir; 1973; 18(6):519-23. PubMed ID: 4790485
[No Abstract] [Full Text] [Related]
3. [Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor].
Fischer PA; Schneider E; Jacobi P; Maxion H
Med Welt; 1973 Nov; 24(45):1742-6. PubMed ID: 4768206
[No Abstract] [Full Text] [Related]
4. [Therapy of Parkinsonian syndrome using L-dopa. Current state and problems].
Fischer PA
Nervenarzt; 1974 Dec; 45(12):617-27. PubMed ID: 4614096
[No Abstract] [Full Text] [Related]
5. [Aspects of hypersexuality observed in parkinsonian patients treated by L-dopa].
Ballivet J; Marin A; Gisselmann A
Ann Med Psychol (Paris); 1973 Nov; 2(4):515-22. PubMed ID: 4799646
[No Abstract] [Full Text] [Related]
6. [L-dopa in the treatment of the Parkinsonian syndrome].
Apostol-Pruskauer B; Voiculescu V
Neurol Psihiatr Neurochir; 1973; 18(6):539-49. PubMed ID: 4790486
[No Abstract] [Full Text] [Related]
7. [Treatment of the parkinsonian syndrome with L-dopa and amantadine].
Pendefunda GH; Pollingher B; Stefanache F; Gavril A; Oprişan C; Merling M; Nemţeanu E; Ciuntu M; Koropitzer I
Neurol Psihiatr Neurochir; 1973; 18(6):559-68. PubMed ID: 4790488
[No Abstract] [Full Text] [Related]
8. [Drug-induced Parkinson's syndrome].
Degkwitz R
Dtsch Med Wochenschr; 1972 Jun; 97(22):882. PubMed ID: 5032182
[No Abstract] [Full Text] [Related]
9. [Pharmacological study of parkinsonian tremor. II. Role of the dopamine-acetylcholine system].
Cerone G; Ruggieri S; Aloisi P; Cappenberg L; Agnoli A
Boll Soc Ital Biol Sper; 1977 Mar; 53(5):349-53. PubMed ID: 901665
[No Abstract] [Full Text] [Related]
10. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
Degkwitz R
Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
[No Abstract] [Full Text] [Related]
11. Physiologic, biochemical, and pathological backgrounds of levodopa and possibilities for the future.
Hornykiewicz OD
Neurology; 1970 Dec; 20(12):1-5. PubMed ID: 5531292
[No Abstract] [Full Text] [Related]
12. [Type II Charcot-Marie-Tooth and dopa-sensitive Parkinson disease].
Tranchant C; Ruh D; Warter JM
Rev Neurol (Paris); 1994; 150(1):72-4. PubMed ID: 7801046
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of parkinsonism with the drug L-DOPA].
Stoliarova LG; Kistenev BA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
[No Abstract] [Full Text] [Related]
14. [Effect of the neuropeptide substance P on the activity of the brain dopaminergic system in experimental parkinsonism].
Krasnova NN; Bychkov ER; Dambinova SA
Fiziol Cheloveka; 1995; 21(1):30-7. PubMed ID: 7535271
[No Abstract] [Full Text] [Related]
15. Stabilographic evaluation of dopaminergic and anticholinergic treatment of parkinsonism.
Cernacek J; Brezny I; Jagr J
Agressologie; 1973; 14(Spec No D):83-7. PubMed ID: 4608340
[No Abstract] [Full Text] [Related]
16. [The effect of prolonged parenteral administration of liposomes and L-Dopa incorporated into liposomes on metabolism of dopamine and its metabolites in the striatum of mice with experimental parkinsonian syndrome].
Iurasov VV; Kucherianu VG; Kudrin VS; Zhigal'tsev IV; Nikushkin EV; Sandalov IuG; Kaplun AP; Shvets VI
Biull Eksp Biol Med; 1997 Feb; 123(2):150-3. PubMed ID: 9280483
[No Abstract] [Full Text] [Related]
17. Role of dopamine in the nervous system.
Barbeau A
Monogr Hum Genet; 1972; 6():114-36. PubMed ID: 4577118
[No Abstract] [Full Text] [Related]
18. [Etiology and therapy of Parkinson's syndrome and related pharmacological concepts shown in experimental models].
Oehme P; Schwarz K
Dtsch Gesundheitsw; 1966 Apr; 21(17):792-8. PubMed ID: 5929188
[No Abstract] [Full Text] [Related]
19. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464
[No Abstract] [Full Text] [Related]
20. [Effect of acidic fibroblast growth factor on experimental parkinsonism and levels of dopamine and its metabolites in the striatum of mice of various ages].
Kucherianu VG; Kryzhanovskiĭ GN; Kudrin VS; Iurasov VV; Nikushkin EV; Zhigal'tsev IV
Biull Eksp Biol Med; 1999 May; 127(5):502-5. PubMed ID: 10399565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
